Company Updates
FDA Approves AccelStim Bone Healing Therapy Device and Expands Orthofix’s Portfolio of Bone Growth Stimulation Solutions
May 4, 2022
LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the…
